C Partners Holding Gmb H Edwards Lifesciences Corp Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$46.41 - $56.94 $38,009 - $46,633	-819 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $40,535 - $51,472	-887 Reduced 51.99%	819 $143,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $2,292 - $2,770	-54 Reduced 3.07%	1,706 $248,000
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $30,049 - $38,339	-808 Reduced 31.46%	1,760 $246,000
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $86,772 - $101,153	2,568	2,568 $289,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.